Evan Russell, DO – FDA 483, Oct 10, 2025
An FDA inspection of Evan Russell, DO in Kansas City, MO, revealed significant deficiencies in clinical research conduct. The firm failed to promptly report unanticipated problems to the IRB and did not conduct an investigation in accordance with the investigational plan, including enrolling ineligible subjects and neglecting data query review. Additionally, issues were found with investigational drug disposition records and the implementation of research activity changes without prior IRB approval.
ID · 63b972d7-8517-4172-8045-8c458bff8093
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.